CompanyGraph
What stands out
- Earnings significantly exceed cash generation
At a glance
- Depends onUpstream position: supplies 8 industries, depends on 0
- ScaleMarket cap is $174.17M, lower than 95% of all stocks globally
- PositionReturn on equity is -35.5%, lower than 95% of its Conglomerates peers (median 5.8%)
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
What stands out
- Earnings significantly exceed cash generation
Financials view
Market Capitalization
8.50BTRY174.17M · vs all stocks (USD)
Revenue (TTM)
0.00TRYvs all stocks (USD)
Profit Margin
0.00%vs Conglomerates peers
Beta
-0.7890xvs all stocks
52-Week Change
-40.49%vs all stocks
Market Capitalization
8.50BTRY174.17M · vs all stocks (USD)
Enterprise Value
0.00TRYvs all stocks (USD)
Price to Book (MRQ)
0.5718xvs Conglomerates peers
Enterprise to EBITDA
-41.33xvs Conglomerates peers
Profit Margin
0.00%vs Conglomerates peers
Operating Margin
0.00%vs Conglomerates peers
Return on Assets (TTM)
-0.71%vs Conglomerates peers
Return on Equity (TTM)
-35.46%vs Conglomerates peers
Revenue (TTM)
0.00TRYvs all stocks (USD)
Revenue per Share (TTM)
0.00TRYUpdated Sep 23, 2026Gross Profit (TTM)
0.00TRYvs all stocks (USD)
Net Income (TTM)
1.46BTRY29.94M · vs all stocks (USD)
Operating Cash Flow (TTM)
-3.13BTRY-64.16M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
1.46BTRY29.94M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.00TRYUpdated Sep 23, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Conglomerates peers
Revenue
0.00TRYFY2025 · Dec 31, 2025Cost of Goods Sold
0.00TRYFY2025 · Dec 31, 2025Gross Profit
0.00TRYFY2025 · Dec 31, 2025Operating Income
-254.56MTRY-5.21M · vs all stocks (USD)
Pre-tax Income
2.71BTRYFY2025 · Dec 31, 2025Income Tax Expense
1.25BTRYFY2025 · Dec 31, 2025Net Income
1.46BTRYFY2025 · Dec 31, 2025EBIT
3.04BTRYFY2025 · Dec 31, 2025EBITDA (Income Statement)
-1.27BTRYFY2025 · Dec 31, 2025Selling, General & Administrative
110.59MTRYFY2025 · Dec 31, 2025Other Operating Expenses
210.92MTRYFY2025 · Dec 31, 2025Non-operating Interest Income
114.47MTRYFY2025 · Dec 31, 2025Non-operating Interest Expense
326.33MTRYFY2025 · Dec 31, 2025Net Income from Continuing Operations
1.46BTRYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00TRYFY2025 · Dec 31, 2025Operating Cash Flow
1.24BTRYFY2025 · Dec 31, 2025Free Cash Flow
1.24BTRYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
190.51MTRYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
1.46BTRYFY2025 · Dec 31, 2025Other Non-cash Items
3.45BTRYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
451.33MTRYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-4.12BTRYFY2025 · Dec 31, 2025Capital Expenditures
148.33KTRYFY2025 · Dec 31, 2025Net Acquisitions
3.33BTRYFY2025 · Dec 31, 2025Net Investing Cash Flow
3.33BTRYFY2025 · Dec 31, 2025Long-term Debt Issuance
364.04MTRYFY2025 · Dec 31, 2025Long-term Debt Payments
-206.51MTRYFY2025 · Dec 31, 2025Net Financing Cash Flow
157.53MTRYFY2025 · Dec 31, 2025Shares Outstanding
1.29BSharesUpdated Sep 23, 2026Float Shares
269.28MSharesUpdated Sep 23, 2026% Held by Insiders
62.11%vs all stocks
% Held by Institutions
0.00%vs all stocks
Total Cash (MRQ)
33.22MTRY680.63K · vs all stocks (USD)
Total Cash per Share (MRQ)
0.4310TRYUpdated Sep 23, 2026Total Debt to Equity (MRQ)
0.0164xvs Conglomerates peers
Current Ratio (MRQ)
1.44xvs Conglomerates peers
Book Value per Share (MRQ)
11.11TRYUpdated Sep 23, 2026Total Assets
18.24BTRY373.69M · vs all stocks (USD)
Total Current Assets
896.78MTRYFY2025 · Dec 31, 2025Total Liabilities
4.71BTRYFY2025 · Dec 31, 2025Total Non-current Assets
17.34BTRYFY2025 · Dec 31, 2025Total Non-current Liabilities
3.73BTRYFY2025 · Dec 31, 2025Total Current Liabilities
982.26MTRYFY2025 · Dec 31, 2025Cash
190.46MTRYFY2025 · Dec 31, 2025Cash Equivalents
52.16KTRYFY2025 · Dec 31, 2025Cash & Cash Equivalents
190.51MTRYFY2025 · Dec 31, 2025Other Short-term Investments
303.65MTRYFY2025 · Dec 31, 2025Accounts Receivable
91.55MTRYFY2025 · Dec 31, 2025Accounts Payable
11.28MTRYFY2025 · Dec 31, 2025Short-term Debt
164.61MTRYFY2025 · Dec 31, 2025Other Current Liabilities
14.53KTRYFY2025 · Dec 31, 2025Common Stock (Book)
1.29BTRYFY2025 · Dec 31, 2025Retained Earnings
11.28BTRYFY2025 · Dec 31, 2025Total Shareholders' Equity
13.53BTRY277.18M · vs all stocks (USD)
52-Week Low
5.72TRYUpdated Sep 23, 202652-Week High
12.48TRYUpdated Sep 23, 202652-Week Change
-40.49%vs all stocks
Beta
-0.7890xvs all stocks
50-Day MA
9.97TRYUpdated Sep 23, 2026200-Day MA
9.52TRYUpdated Sep 23, 2026Avg 10-Day Volume
43.20MSharesUpdated Sep 23, 2026Avg 30-Day Volume
33.07MSharesUpdated Sep 23, 2026Diluted EPS (TTM)
-3.96TRYUpdated Sep 23, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Return on equity is -35.5%, lower than 95% of its Conglomerates peers (median 5.8%)Significant
Return on equity: -0.35Industry median: 0.06Industry P5: -0.17Peers compared: 100
Structural Tensions
Earnings significantly exceed cash generationSignificant
Net Income (USD, TTM): 29,944,090.013Operating Cash Flow (USD, TTM): -64,158,567.073
Financial Health
Altman Z-Score 2.49: grey zoneSignificant
Altman Z-Score: 2.49
Supply Chain
Upstream position: supplies 8 industries, depends on 0Notable
Outgoing: 8.00Incoming: 0.00
Scale
Market cap is $174.17M, lower than 95% of all stocks globallySignificant
Market cap (USD): 174,173,785.011Global P5: 275,556,405.438
Revenue is $0, lower than 95% of all stocks globallySignificant
Revenue (USD): 0.00Global P5: 33,357,653.812
Levered free cash flow is $29.94M, above the global median of $18.73MNotable
Levered free cash flow (USD): 29,944,090.013Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Salam International Investment Limited
Tier 1RiskThroughput-Bound ConversionInterfaceProduction
Sinad Holding Co.
Tier 1RiskThroughput-Bound ConversionInterfaceSenseMaking
Karnell Group AB ser. B
Tier 1RiskThroughput-Bound ConversionSenseMakingInterface
Boston Omaha Corporation
Tier 1RiskThroughput-Bound ConversionInterfaceAttention
Medicare Group Inc.
Tier 1RiskThroughput-Bound ConversionInterfaceRule
Pasifik Holding A.S.
Tier 1RiskThroughput-Bound ConversionInterfaceSenseMaking
Jiangsu Baoli International Investment Co., Ltd.
Tier 1RiskThroughput-Bound ConversionInterfaceSenseMaking
Eczacibasi Yatirim Holding A.S.
Tier 1RiskThroughput-Bound ConversionSenseMakingInterface
Lydia Holding AS
Tier 1RiskThroughput-Bound ConversionInterfaceSenseMaking
Jiangsu Yueda Investment Co., Ltd.
Tier 1RiskThroughput-Bound ConversionSenseMakingInterface
Companies that share active interpretations — structural patterns currently present in both stocks.
Anbio Biotechnology Limited
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Md Entertainment Tbk
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Beijing Xiaocheng Technology Co. Ltd.
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated